TEVA logo

TEVA Cost of goods sold

annual cost of goods sold:

$8.48B+$281.00M(+3.43%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TEVA annual cost of goods sold is $8.48 billion, with the most recent change of +$281.00 million (+3.43%) on December 31, 2024.
  • During the last 3 years, TEVA annual cost of goods sold has risen by +$197.00 million (+2.38%).
  • TEVA annual cost of goods sold is now -24.53% below its all-time high of $11.24 billion, reached on December 31, 2017.

Performance

TEVA Cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

quarterly cost of goods sold:

$2.01B-$95.00M(-4.50%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA quarterly cost of goods sold is $2.01 billion, with the most recent change of -$95.00 million (-4.50%) on March 31, 2025.
  • Over the past year, TEVA quarterly cost of goods sold has dropped by -$34.00 million (-1.66%).
  • TEVA quarterly cost of goods sold is now -39.12% below its all-time high of $3.31 billion, reached on December 31, 2016.

Performance

TEVA quarterly cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

TTM cost of goods sold:

$8.45B-$34.00M(-0.40%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TEVA TTM cost of goods sold is $8.45 billion, with the most recent change of -$34.00 million (-0.40%) on March 31, 2025.
  • Over the past year, TEVA TTM cost of goods sold has increased by +$276.00 million (+3.38%).
  • TEVA TTM cost of goods sold is now -29.33% below its all-time high of $11.95 billion, reached on September 30, 2017.

Performance

TEVA TTM cost of goods sold Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTEVAincome statement metrics

Cost of goods sold Formula

COGS = Beginning Inventory + Purchases − Ending Inventory

TEVA Cost of goods sold Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+3.4%-1.7%+3.4%
3 y3 years+2.4%+4.8%+4.3%
5 y5 years-9.3%-12.2%-9.7%

TEVA Cost of goods sold Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+6.7%-7.7%+4.8%-0.4%+7.1%
5 y5-year-9.3%+6.7%-16.3%+4.8%-9.7%+7.1%
alltimeall time-24.5%>+9999.0%-39.1%+1560.3%-29.3%+4853.7%

TEVA Cost of goods sold History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.01B(-4.5%)
$8.45B(-0.4%)
Dec 2024
$8.48B(+3.4%)
$2.11B(-3.4%)
$8.48B(+0.8%)
Sep 2024
-
$2.18B(+2.0%)
$8.41B(+2.2%)
Jun 2024
-
$2.14B(+4.5%)
$8.23B(+0.7%)
Mar 2024
-
$2.05B(+0.3%)
$8.17B(-0.4%)
Dec 2023
$8.20B(+3.1%)
$2.04B(+2.1%)
$8.20B(-0.9%)
Sep 2023
-
$2.00B(-4.0%)
$8.27B(+0.9%)
Jun 2023
-
$2.08B(+0.1%)
$8.20B(+1.1%)
Mar 2023
-
$2.08B(-1.6%)
$8.11B(+2.0%)
Dec 2022
$7.95B(-4.0%)
$2.11B(+9.7%)
$7.95B(+0.8%)
Sep 2022
-
$1.93B(-3.3%)
$7.89B(-2.1%)
Jun 2022
-
$1.99B(+3.7%)
$8.06B(-0.6%)
Mar 2022
-
$1.92B(-6.3%)
$8.10B(-2.2%)
Dec 2021
$8.28B(-7.3%)
$2.05B(-2.1%)
$8.28B(-4.1%)
Sep 2021
-
$2.09B(+2.7%)
$8.64B(-0.4%)
Jun 2021
-
$2.04B(-3.2%)
$8.67B(-0.8%)
Mar 2021
-
$2.10B(-12.5%)
$8.74B(-2.1%)
Dec 2020
$8.93B(-4.5%)
$2.40B(+13.1%)
$8.93B(-1.2%)
Sep 2020
-
$2.13B(+0.9%)
$9.04B(-1.5%)
Jun 2020
-
$2.11B(-8.2%)
$9.17B(-1.9%)
Mar 2020
-
$2.29B(-8.6%)
$9.35B(+0.0%)
Dec 2019
$9.35B(-6.3%)
$2.51B(+10.9%)
$9.35B(+5.7%)
Sep 2019
-
$2.26B(-0.9%)
$8.85B(-3.2%)
Jun 2019
-
$2.28B(-0.4%)
$9.13B(-4.0%)
Mar 2019
-
$2.29B(+14.4%)
$9.52B(-4.6%)
Dec 2018
$9.97B(-11.2%)
$2.00B(-21.4%)
$9.97B(-5.6%)
Sep 2018
-
$2.55B(-4.3%)
$10.56B(-3.8%)
Jun 2018
-
$2.67B(-3.0%)
$10.98B(-1.8%)
Mar 2018
-
$2.75B(+6.0%)
$11.18B(-0.5%)
Dec 2017
$11.24B(+9.6%)
$2.59B(-12.6%)
$11.24B(-6.0%)
Sep 2017
-
$2.97B(+3.6%)
$11.95B(+1.7%)
Jun 2017
-
$2.87B(+1.9%)
$11.75B(+6.4%)
Mar 2017
-
$2.81B(-15.0%)
$11.04B(+7.7%)
Dec 2016
$10.25B(+23.6%)
$3.31B(+19.8%)
$10.25B(+14.2%)
Sep 2016
-
$2.76B(+27.8%)
$8.98B(+8.6%)
Jun 2016
-
$2.16B(+7.0%)
$8.27B(+1.2%)
Mar 2016
-
$2.02B(-0.7%)
$8.17B(-1.5%)
Dec 2015
$8.30B(-10.0%)
$2.03B(-0.9%)
$8.30B(-2.9%)
Sep 2015
-
$2.05B(-0.6%)
$8.54B(-2.3%)
Jun 2015
-
$2.06B(-3.8%)
$8.74B(-3.5%)
Mar 2015
-
$2.15B(-5.8%)
$9.06B(-1.7%)
Dec 2014
$9.22B(-4.1%)
$2.28B(+1.3%)
$9.22B(-2.7%)
Sep 2014
-
$2.25B(-5.7%)
$9.47B(-1.9%)
Jun 2014
-
$2.38B(+3.5%)
$9.65B(+0.6%)
Mar 2014
-
$2.30B(-9.1%)
$9.60B(-0.1%)
Dec 2013
$9.61B(-0.6%)
$2.54B(+4.4%)
$9.61B(+0.8%)
Sep 2013
-
$2.43B(+4.2%)
$9.54B(+0.6%)
Jun 2013
-
$2.33B(+0.9%)
$9.48B(-0.1%)
Mar 2013
-
$2.31B(-6.2%)
$9.48B(-1.9%)
Dec 2012
$9.66B(+9.9%)
$2.46B(+3.9%)
$9.66B(-3.3%)
Sep 2012
-
$2.37B(+1.5%)
$10.00B(+2.8%)
Jun 2012
-
$2.34B(-6.3%)
$9.72B(+3.5%)
Mar 2012
-
$2.49B(-10.8%)
$9.40B(+6.8%)
Dec 2011
$8.80B(+24.7%)
$2.79B(+33.2%)
$8.80B(+10.6%)
Sep 2011
-
$2.10B(+4.3%)
$7.96B(+4.1%)
Jun 2011
-
$2.01B(+6.3%)
$7.64B(+4.6%)
Mar 2011
-
$1.89B(-3.2%)
$7.31B(+3.6%)
Dec 2010
$7.06B
$1.95B(+9.6%)
$7.06B(+3.7%)
Sep 2010
-
$1.78B(+6.2%)
$6.80B(+2.4%)
Jun 2010
-
$1.68B(+2.4%)
$6.64B(+0.7%)
DateAnnualQuarterlyTTM
Mar 2010
-
$1.64B(-3.7%)
$6.60B(+1.0%)
Dec 2009
$6.53B(+27.7%)
$1.70B(+5.0%)
$6.53B(+7.5%)
Sep 2009
-
$1.62B(-0.6%)
$6.08B(+4.7%)
Jun 2009
-
$1.63B(+3.5%)
$5.81B(+5.7%)
Mar 2009
-
$1.58B(+26.2%)
$5.49B(+7.3%)
Dec 2008
$5.12B(+12.9%)
$1.25B(-7.5%)
$5.12B(+0.4%)
Sep 2008
-
$1.35B(+2.4%)
$5.10B(+4.8%)
Jun 2008
-
$1.32B(+9.8%)
$4.86B(+3.7%)
Mar 2008
-
$1.20B(-2.4%)
$4.69B(+3.5%)
Dec 2007
$4.53B(+9.2%)
$1.23B(+10.1%)
$4.53B(+1.2%)
Sep 2007
-
$1.12B(-2.4%)
$4.48B(+2.1%)
Jun 2007
-
$1.14B(+9.6%)
$4.38B(+3.3%)
Mar 2007
-
$1.04B(-11.2%)
$4.24B(+2.3%)
Dec 2006
$4.15B(+49.8%)
$1.17B(+14.7%)
$4.15B(+12.2%)
Sep 2006
-
$1.02B(+2.3%)
$3.70B(+9.6%)
Jun 2006
-
$1.00B(+5.5%)
$3.37B(+11.8%)
Mar 2006
-
$949.00M(+31.0%)
$3.02B(+8.9%)
Dec 2005
$2.77B(+8.2%)
$724.70M(+3.7%)
$2.77B(+0.6%)
Sep 2005
-
$698.70M(+8.3%)
$2.75B(+1.5%)
Jun 2005
-
$645.40M(-8.0%)
$2.71B(+0.8%)
Mar 2005
-
$701.20M(-0.8%)
$2.69B(+5.0%)
Dec 2004
$2.56B(+45.7%)
$707.20M(+7.5%)
$2.56B(+8.4%)
Sep 2004
-
$657.70M(+5.6%)
$2.36B(+10.4%)
Jun 2004
-
$623.10M(+8.9%)
$2.14B(+11.4%)
Mar 2004
-
$572.00M(+12.4%)
$1.92B(+9.3%)
Dec 2003
$1.76B(+23.5%)
$509.00M(+16.9%)
$1.76B(+4.6%)
Sep 2003
-
$435.40M(+7.7%)
$1.68B(+4.7%)
Jun 2003
-
$404.10M(-1.2%)
$1.60B(+5.2%)
Mar 2003
-
$409.00M(-5.1%)
$1.53B(+7.2%)
Dec 2002
$1.42B(+15.7%)
$431.00M(+19.5%)
$1.42B(+7.9%)
Sep 2002
-
$360.70M(+11.0%)
$1.32B(+4.8%)
Jun 2002
-
$324.90M(+6.0%)
$1.26B(+1.3%)
Mar 2002
-
$306.60M(-6.3%)
$1.24B(+1.0%)
Dec 2001
$1.23B(+27.7%)
$327.18M(+9.1%)
$1.23B(+9.8%)
Sep 2001
-
$300.00M(-2.9%)
$1.12B(+2.8%)
Jun 2001
-
$308.85M(+5.1%)
$1.09B(+5.6%)
Mar 2001
-
$293.96M(+35.0%)
$1.03B(+10.0%)
Dec 2000
$962.99M(+37.7%)
$217.80M(-19.3%)
$938.37M(+6.7%)
Sep 2000
-
$269.72M(+7.4%)
$879.38M(+9.6%)
Jun 2000
-
$251.10M(+25.7%)
$802.36M(+10.8%)
Mar 2000
-
$199.75M(+25.8%)
$724.15M(+3.6%)
Dec 1999
$699.20M(+9.9%)
$158.80M(-17.6%)
$699.20M(+5.7%)
Sep 1999
-
$192.70M(+11.5%)
$661.70M(+1.0%)
Jun 1999
-
$172.90M(-1.1%)
$655.00M(+2.3%)
Mar 1999
-
$174.80M(+44.1%)
$640.50M(+0.7%)
Dec 1998
$636.10M(+1.1%)
$121.30M(-34.8%)
$636.20M(+23.6%)
Sep 1998
-
$186.00M(+17.4%)
$514.90M(+56.6%)
Jun 1998
-
$158.40M(-7.1%)
$328.90M(+92.9%)
Mar 1998
-
$170.50M
$170.50M
Dec 1997
$628.90M(+14.3%)
-
-
Dec 1996
$550.40M(+14.3%)
-
-
Dec 1995
$481.50M(+15.7%)
-
-
Dec 1994
$416.20M(+55.0%)
-
-
Dec 1993
$268.50M(+20.0%)
-
-
Dec 1992
$223.80M(+15.3%)
-
-
Dec 1991
$194.10M(+1.5%)
-
-
Dec 1990
$191.30M(+5.9%)
-
-
Dec 1989
$180.70M(+39.5%)
-
-
Dec 1988
$129.50M(+52.5%)
-
-
Mar 1987
$84.90M(+44.4%)
-
-
Mar 1986
$58.80M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual cost of goods sold year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold year-on-year change?
  • What is Teva Pharmaceutical Industries Limited TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited TTM cost of goods sold year-on-year change?

What is Teva Pharmaceutical Industries Limited annual cost of goods sold?

The current annual cost of goods sold of TEVA is $8.48B

What is the all time high annual cost of goods sold for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual cost of goods sold is $11.24B

What is Teva Pharmaceutical Industries Limited annual cost of goods sold year-on-year change?

Over the past year, TEVA annual cost of goods sold has changed by +$281.00M (+3.43%)

What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold?

The current quarterly cost of goods sold of TEVA is $2.01B

What is the all time high quarterly cost of goods sold for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly cost of goods sold is $3.31B

What is Teva Pharmaceutical Industries Limited quarterly cost of goods sold year-on-year change?

Over the past year, TEVA quarterly cost of goods sold has changed by -$34.00M (-1.66%)

What is Teva Pharmaceutical Industries Limited TTM cost of goods sold?

The current TTM cost of goods sold of TEVA is $8.45B

What is the all time high TTM cost of goods sold for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM cost of goods sold is $11.95B

What is Teva Pharmaceutical Industries Limited TTM cost of goods sold year-on-year change?

Over the past year, TEVA TTM cost of goods sold has changed by +$276.00M (+3.38%)
On this page